Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

October 31, 1999

Conditions
Lung Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

docetaxel

DRUG

vinorelbine tartrate

Trial Locations (19)

10595

New York Medical College, Valhalla

10956

Hematology-Oncology Associates of Rockland, P.C., New City

11209

Veterans Affairs Medical Center - Brooklyn, Brooklyn

20016

Sibley Memorial Hospital, Washington D.C.

20422

Veterans Affairs Medical Center - Washington, DC, Washington D.C.

23226

Hematology & Oncology Associates of Virginia, Richmond

26505

Morgantown Internal Medicine Group, Morgantown

29403

Charleston Hematology-Oncology, P.A., Charleston

29406

Trident Palmetto Hematology/Oncology, North Charleston

30274

Georgia Cancer Treatment Center, P.C., Riverdale

38119

Boston Baskin Cancer Group, University Tennessee Oncology/Hematology Group, Memphis

44131

Community Oncology Group, Independence

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

45429

CCOP - Dayton, Kettering

66205

Oncology and Hematology Associates, Westwood

76104

Texas Cancer Care, Fort Worth

95353

Gould Medical Group, Modesto

43623-3456

CCOP - Toledo Community Hospital Oncology Program, Toledo

77555-0209

University of Texas Medical Branch, Galveston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY